Apprendre à traduire à partir d'exemples de traductions humaines.
De: Traduction automatique
Suggérer une meilleure traduction
Qualité :
Réalisées par des traducteurs professionnels, des entreprises, des pages web ou traductions disponibles gratuitement.
za bolesnike u kojih glikemija nije odgovarajuće regulirana dvojnom kombiniranom terapijom najvišom podnošljivim dozom metformina i agonista ppar
for patients inadequately controlled on dual combination therapy with the maximal tolerated dose of metformin and a ppar agonist
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
metforminom i tiazolidindionom u odraslih bolesnika u kojih glikemija nije dovoljno dobro regulirana najvišim podnošljivim dozama ovih peroralnih lijekova.
metformin and a thiazolidinedione in adults who have not achieved adequate glycaemic control on maximally tolerated doses of these oral therapies.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
lijek competact primjenjuje se u bolesnika koji ne mogu postići zadovoljavajuću kontrolu samo metforminom (lijekom za liječenje dijabetesa) u najvišim podnošljivim dozama.
competact is used in patients who are not satisfactorily controlled on metformin (a diabetes medicine) used on its own and at the maximum possible dose.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
u ovom se ispitivanju naloksegol u dozama od 12,5 mg i 25 mg pokazao općenito sigurnim i dobro podnošljivim u usporedbi s placebom u liječenju bolesnika s konstipacijom uzrokovanom primjenom opioida i boli koja nije uzrokovana rakom.
in this study, naloxegol at doses of 12.5 mg and 25 mg was generally safe and well tolerated as compared with placebo in the treatment of oic patients with non-cancer-related pain.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
competact je indiciran kao druga linija liječenja šećerne bolesti tipa 2 u odraslih bolesnika, osobito onih s prekomjernom tjelesnom težinom, koji ne mogu postići zadovoljavajuću kontrolu glikemije samo peroralnim metforminom u najvišim podnošljivim dozama.
competact is indicated as second line treatment of type 2 diabetes mellitus adult patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
primjenjuje se s drugim lijekovima za liječenje šećerne bolesti u odraslih bolesnika čije se razine glukoze (šećera) u krvi ne mogu odgovarajuće kontrolirati najvišim podnošljivim dozama drugih lijekova.
it is used together with other diabetes medicines in adult patients whose blood glucose (sugar) levels are not adequately controlled with the maximum tolerated doses of the other medicines.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
dodavanje lijeka cholestagel u dozi od 3,8 g na dan u terapiju maksimalnim podnošljivim dozama statina i ezetimiba ocijenjeno je u multicentričnom, randomiziranom, dvostruko slijepom, placebo kontroliranom ispitivanju s paralelnim skupinama, u 86 bolesnika s obiteljskom hiperkolesterolemijom.
the addition of cholestagel 3.8 g daily to maximally-tolerated statin and ezetimibe therapy was assessed in a multi-centre, randomised, double-blind, placebo-controlled study in 86 patients with familial hypercholesterolaemia.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :